Robot vs. standard surgery: which is safer for Women's cancers?

NCT ID NCT01247779

Completed Knowledge-focused Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 386 women with cervical, uterine, or ovarian cancer to compare standard laparoscopic surgery versus robot-assisted laparoscopic surgery. The goal was to see which approach causes fewer complications within six months after the operation. Researchers tracked side effects, pain control, and surgeon comfort to help guide future surgical choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose the safer surgical method for women with gynecologic cancers.
What could go wrong: This is an observational comparison, not a treatment test. Results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer neoplasm ovarian cancer uterine cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER OVARIAN CANCER UTERUS CANCER

Contacts and locations

Locations

CHRU Lille, Hôpital Jeanne de Flandres

Lille, 59037, France
CHRU de Tours

Tours, 37044, France
CHU Bordeaux, Hôpital Saint-André

Bordeaux, 33300, France
CHU Limoges

Limoges, 87042, France
CHU Nîmes

Nîmes, 30029, France
CHU Rangueil

Toulouse, 31059, France
Centre Alexis Vautrin

Vandœuvre-lès-Nancy, 54511, France
Centre Hospitalier de Valenciennes

Valenciennes, 59322, France
Centre Oscar Lambret

Lille, 59000, France
Centre hospitalier de Roubaix

Roubaix, 59056, France
Hôpital Européen Georges Pompidou

Paris, 75015, France
Institut Claudius Regaud

Toulouse, 31052, France
Institut Paoli Calmette

Marseille, 13009, France
Institut de Cancérologie de l'Ouest Site René Gauducheau

Saint-Herblain, 44805, France
Polyclinique Bordeaux Nord Aquitaine

Bordeaux, 33300, France
Polyclinique Courlancy

Reims, 51100, France
Polyclinique KenVal

Nîmes, 30900, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.